Use of Marek’s disease vaccines: could they be driving the virus to increasing virulence?

References

• Marek J. Multiple nerventzundung (polyneuritis) bei huhnern. Deutsche Tierartzzeitung Wschr15, 417–421 (1907).
   Google Scholar
• Pappenheimer AM, Dunn LC, Cone V. A study of fowl paralysis (neurolymphomatosis gallinarum). Storrs Agri. Exp. Stat. Bull.143, 186–190 (1926).
   Google Scholar
• Biggs PM. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 8–16 (2004).
   Google Scholar
• Payne LN. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 79–97 (2004).
   Google Scholar
• Farrant J. Houghton Poultry Research Station: scourge of the pathogens. Poultry World15–20 (1969).
   PubMed Web of Science ®Google Scholar
• Powell PC. Marek’s disease – a worldwide problem. World’s Poultry Sci. J.42, 205–218 (1986).
   Web of Science ®Google Scholar
• Churchill AE, Biggs PM. Agent of Marek’s disease in tissue culture. Nature215, 528–530 (1967).
   PubMed Web of Science ®Google Scholar
• Churchill AE, Chubb RC. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek’s disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol.4, 557–564 (1969).
   PubMed Web of Science ®Google Scholar
• Witter RL, Nazerian K, Purchase HG, Burgoyne GH. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek’s disease virus. Am. J. Vet. Res.31, 525–538 (1970).
   PubMed Web of Science ®Google Scholar
• Witter RL. Characteristics of Marek’s disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis.27, 113–132 (1983).
   PubMed Web of Science ®Google Scholar
• Calnek BW, Schat KA, Peckham MC, Fabricant J. Field trials with a bivalent vaccine (HVT and SB-1) against Marek’s disease. Avian Dis.27, 844–849 (1983).
   PubMed Web of Science ®Google Scholar
• Witter RL. Increased virulence of Marek’s disease virus field isolates. Avian Dis.41, 149–163 (1997).
   PubMed Web of Science ®Google Scholar
• Morrow C, Fehler F. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 49–61 (2004).
   Google Scholar
• Osterrieder K, Vautherot JF. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 17–31 (2004).
   Google Scholar
• Buckmaster AE, Scott SD, Sanderson MJ et al. Gene sequence and mapping data from Mareks disease virus and herpesvirus of turkeys – implications for herpesvirus classification. J. Gen. Virol.69, 2033–2042 (1988).
   PubMed Web of Science ®Google Scholar
• Roizman B, Pellett PE. In: Field’s Virology. Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, PA, USA, 2381–2398 (2001).
   Google Scholar
• Izumiya Y, Jang H-K, Sugawara M et al. Identification and transcriptional analysis of the homologues of the herpes simplex virus Type 1 UL30 to UL40 genes in the genome of nononcogenic Marek’s disease virus serotype 2. J. Gen. Virol.80, 2417–2422 (1999).
   PubMed Web of Science ®Google Scholar
• Lee LF et al. The complete unique long sequence and the overall genomic organization of the GA strain of Marek’s disease virus. Proc. Natl Acad. Sci. USA97, 6091–6096 (2000).
   PubMed Web of Science ®Google Scholar
• Tulman ER, Afonso CL, Lu Z et al. The genome of a very virulent Marek’s disease virus. J. Virol.74, 7980–7988 (2000).
   PubMed Web of Science ®Google Scholar
• Alfonso CL, Tulman ER, Lu Z et al. The genome of herpesvirus of turkeys. J. Virol.75, 971–978 (2000).
   Web of Science ®Google Scholar
• Baigent S, Davison F. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 52–77 (2004).
   Google Scholar
• Silver S, Tanaka A, Nonoyama M. Transcription of Marek’s disease virus genome in a nonproductive chicken lymphoblastoid cell line. Virology93, 127–133 (1979).
   PubMed Web of Science ®Google Scholar
• Carrozza JH, Fredrickson TN, Prince RP, Luginbuhl RE. Role of desquamated epithelial cells in transmission of Marek’s disease. Avian Dis.17, 767–781 (1973).
   PubMed Web of Science ®Google Scholar
• Calnek BW. Marek’s disease – a model for herpesvirus oncology. Crit. Rev. Microbiol.12, 293–320 (1986).
   PubMed Web of Science ®Google Scholar
• Burgess SC et al. Marek’s disease is a natural model for lymphomas overexpressing Hodgkin’s disease antigen (CD30). Proc. Natl Acad. Sci. USA101, 13879–13884 (2004).
   PubMed Web of Science ®Google Scholar
• Delecluse HJ, Schuller S, Hammerschmidt W. Latent Marek’s disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells. EMBO J.12, 3277–3286 (1993).
   PubMed Web of Science ®Google Scholar
• Burgess SC, Davison TF. Identification of the neoplastically transformed cells in Marek’s disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J. Virol.76, 7276–7292 (2002).
   PubMed Web of Science ®Google Scholar
• Bumstead N, Kaufman J. In: Marek’s Disease: An Evolving Problem. Davison F, Nair Vk (Eds). Elsevier, London, Uk, 112–125 (2004).
   Google Scholar
• Dalgaard T, Skjodt K, Juul-Madsen HR. Differences in chicken major histocompatability (MHC) class α-gene expression between Marek’s disease-resistant and susceptible MHC haplotypes. Scand. J. Immunol.57, 135–143 (2003).
   PubMed Web of Science ®Google Scholar
• Bumstead N. Genomic mapping of resistance to Marek’s disease. Avian Pathol.27, S78–S81 (1998).
   Web of Science ®Google Scholar
• Scalzo AA, Fitzgerald NA, Simmons A, Lavista AB, Shellam GR. CMV-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med.171, 1469–1483 (1990).
   PubMed Web of Science ®Google Scholar
• Scalzo AA, Fitzgerald NA, Wallace CR et al. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol.149, 581–589 (1992).
   PubMed Web of Science ®Google Scholar
• Davison F, Kaiser P. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 126–141 (2004).
   Google Scholar
• Calnek BW. Effects of passive antibody on early pathogenesis of Marek’s disease. Infect. Immun.6, 193–205 (1972).
   PubMed Web of Science ®Google Scholar
• Chubb RC, Churchill AE. Effect of maternal antibody on Marek’s disease. Vet. Rec.85, 303–305 (1969).
   PubMed Web of Science ®Google Scholar
• Buscaglia C, Calnek BW, Schat KA. Effect of immunocompetence on the establishment and maintenance of latency with Marek’s disease herpesvirus. J. Gen. Virol.69, 1067–1077 (1988).
   PubMed Web of Science ®Google Scholar
• Powell PC, Davison F. Induction of Marek’s disease in vaccinated chickens by treatment with betamethason or corticosterone. Israel J. Vet. Med.42, 73–78 (1986).
   Google Scholar
• Schat AK. In: Marek’s disease: An evolving problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 142–155 (2004).
   Google Scholar
• Okazaki W, Purchase HG, Burmester BR. Protection against Marek’s disease by vaccination with a herpesvirus of turkeys. Avian Dis.14, 413–429 (1970).
   PubMed Web of Science ®Google Scholar
• Rispens BH, Vloten Van HJ, Mastenbroek H, Maas HJL, Schat KA. Control of Marek’s disease in The Netherlands. I. Isolation of an avirulent Marek’s disease virus (strain CVI988) and its use in laboratory vaccination trials. Avian Dis.16, 108–125 (1972).
   PubMed Web of Science ®Google Scholar
• Von Bulow V. Further charateristics of the CVI988 strain of Marek’s disease virus. Avian Pathol.6, 395–403 (1977).
   PubMed Web of Science ®Google Scholar
• Witter RL, Lee LF, Fadly AM. Characteristics of the CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek’s disease virus. Avian Dis.39, 269–284 (1995).
   PubMed Web of Science ®Google Scholar
• Witter RL. In: Current Topics in Microbiology and Immunology. Hirai K (Ed.). Springer, Berlin, Germany, 57–90 (2001).
   Google Scholar
• Bublot M, Sharma JM. In: Marek’s Disease: An Evolving Problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 168–185 (2004).
   Google Scholar
• Karpathy RC, Firth GA, Tannock GA. Derivation, safety and efficacy of a Marek’s disease vaccine, developed from an Australian isolate of very virulent Marek’s disease virus. Australian Vet. J.80, 61–66 (2002).
   PubMed Web of Science ®Google Scholar
• Karpathy RC, Firth GA, Tannock GA. Field evaluations of safety and efficacy of an Australian Marek’s disease vaccine. Australian Vet. J.81, 222–225 (2003).
   PubMed Web of Science ®Google Scholar
• Witter RL. Attenuated revertant serotype 1 Marek’s disease viruses – safety and protective efficacy. Avian Dis.35, 877–891 (1991).
   PubMed Web of Science ®Google Scholar
• Sharma JM, Burmester BR. Resistance toMarek’s disease at hatching in chicks vaccinated as embryos with turkey herpesvirus. Avian Dis.26, 134–149 (1982).
   PubMed Web of Science ®Google Scholar
• Sharma JM, Ahmad J. In: Advances in Avian Immunology Research. Davison F, Bumstead N, Kaiser P (Eds). Abingdon, UK, 273–277 (1995).
   Google Scholar
• Fadly AM, Silva RF, Hunt H. In: NE 107th Annual Meeting of the United States Animal Health Association. CA, USA, 524 (2003).
   Google Scholar
• Witter RL. The changing landscape of Marek’s disease. Avian Pathol.27, S46–S53 (1998).
   Web of Science ®Google Scholar
• Nair VK. Evolution odf Marek’s disease – a paradigm for incessant race between the pathogen and the host. Vet. J. (2005) (In Press).
   PubMed Web of Science ®Google Scholar
• Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature414, 751–756 (2001).
   PubMed Web of Science ®Google Scholar
• Witter RL, Li D, Jones D, Lee LF, Kung HJ. Retroviral insertional mutagenesis of a herpesvirus: a Marek’s disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. Avian Dis.41, 407–421 (1997).
   PubMed Web of Science ®Google Scholar
• Gimeno IM. In: Marek’s disease: An evolving problem. Davison F, Nair VK (Eds). Elsevier, London, UK, 186–199 (2004).
   Google Scholar
• Nazerian K, Lee L, Yanagida N, Ogawa R. Protection against Marek’s disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek’s disease virus. J. Virol.66, 1409–1413 (1992).
   PubMed Web of Science ®Google Scholar
• Nazerian K, Witter R, Lee L, Yanagida N. Protection and synergism by recombinant fowlpox vaccines expressing genes from Marek’s disease virus. Avian Dis.40, 368–376 (1996).
   PubMed Web of Science ®Google Scholar
• Heine HG et al. Recombinant fowlpox virus vaccines against Australian virulent Marek’s disease virus: gene sequence analysis and comparison of vaccine efficacy in specific-pathogen-free and production chickens. Virus Res.50, 23–33 (1997).
   PubMed Web of Science ®Google Scholar
• Liu X, Peng D, Wu X, Xing L, Zhang R. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens. Acta Virologica43, 201–204 (1999).
   PubMed Web of Science ®Google Scholar
• Lee LF, Foord AJ, Young PL et al. Protection and synergism by recombinant fowlpox vaccines expressing multiple genes from Marek’s disease virus. Avian Dis.47, 549–558 (2003).
   PubMed Web of Science ®Google Scholar
• Reddy S, Sharma JM, Ahmad J et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek’s diseases in specific-pathogen-free chickens. Vaccine14, 469–477 (1996).
   PubMed Web of Science ®Google Scholar
• Reddy SM, Lupiani B, Gimeno IM et al. Rescue of a pathogenic Marek’s disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl Acad. Sci. USA99, 7054–7059 (2002).
   PubMed Web of Science ®Google Scholar
• Schumacher D, Tischer BK, Fuchs W, Osterrieder N. Reconstitution of Marek’s disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol.74, 11088–11098 (2000).
   PubMed Web of Science ®Google Scholar
• Tarpey I, Davis PJ, Sondermeijer P. In: Workshop on Molecular Pathogenesis of Marek’s disease and Avian Immunology. Davidson I, Heller D (Eds). Kimron Institute, Bet Dagan, Israel, Limmasol, Cyprus (2002).
   Google Scholar
• Lee LL, Bacon LD, Yoshida A et al. The efficacy of recombinant fowlpox vaccine protection against Marek’s disease: its dependence on chicken line and B haplotype. Avian Dis.48, 129–137 (2004).
   Google Scholar
• Lupiani B, Lee LF, Cui X et al. Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl Acad. Sci. USA101, 11815–11820.
   Google Scholar